Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this study is to compare pain after uterine artery embolization using spherical gelfoam or tris-acryl gelatin microsphere in patients with symptomatic fibroids


Clinical Trial Description

Uterine artery embolization(UAE) is a minimally invasive treatment alternative to hysterectomy and myomectomy in symptomatic fibroids. However, post-procedural pain after UAE remains a major problem. The spherical gelfoam and tri-acryl gelatin microsphere are two embolic materials used for UAE. Therefore, the aim of study is to compare pain intensity and inflammation after uterine artery embolization using the two embolic agents with symptomatic fibroids. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04960293
Study type Interventional
Source Yonsei University
Contact Man-Deuk Kim
Phone 82-10-8625-2197
Email mdkim@yuhs.ac
Status Not yet recruiting
Phase N/A
Start date July 2021
Completion date May 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02163525 - Post Market TRUST - U.S.A. Study N/A
Withdrawn NCT01735812 - Laparoscopic Cryoablation of Uterine Fibroids N/A